Q2: What does the KLOW peptide blend research focus on
The result was the very first LifeWave patch, the Energy Enhancer , designed to help the body access its own stored fat for energy, without anything being put into the body
Next, we treated AC16 cells with increasing doses of rosiglitazone (25, 50, and 100 M) and WY-14643 (25, 50, and 100 M) to identify the minimum dose of rosiglitazone that increases PPARGC1A expression (Supplemental Figure 3, AC) and the maximum dose of WY-14643 that does not (Supplemental Figure 3, DF)
The results were expressed in jimol GSH/g tissue
You will need Acrobat Reader to (note:this is a huge file)[13mb]
Researchers found that diabetes patients had a glutathione deficiency, compared to subjects without diabetes